CFS LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

CFS LLC’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-8,955	Closed	-$87K	–	133
2013 Q4	$87K	Buy	+8,955	New	+$80.4K	0.08%	60

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CFS LLC's IRWD Position: Q1 2014 in Review

CFS LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2014, closing a stake of 8,955 shares — an estimated $87K sold.

CFS LLC first reported a position in IRWD in Q4 2013 and held it in 1 quarter. The position peaked at $87K in Q4 2013. 138 funds tracked by Wall St. Rank hold IRWD as of Q1 2014.

CFS LLC reported no remaining Ironwood Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
CFS LLC sold 8,955 Ironwood Pharmaceuticals shares in Q1 2014, an estimated $87K.
CFS LLC first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 1 quarter.
CFS LLC's Ironwood Pharmaceuticals position peaked at $87K in Q4 2013.
138 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2014.

Based on CFS LLC's 13F filing for Q1 2014, filed 7 May 2014.